SCHEMBL3653256

SCHEMBL3653256

O=C(O)N(CO)CCC1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 3/20 0.41
PHF8 Q9UPP1 3/20 0.41
KDM2A Q9Y2K7 3/20 0.41
KDM4C Q9H3R0 2/20 0.41
KDM4A O75164 1/20 0.41
ALOX5 P09917 3/20 0.40
HPGD P15428 1/20 0.38
CASR P41180 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
EPHX1 P07099 1/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MMP3 P08254 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4667724 0.87 KDM5A (0.40) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL4669117 0.81 KDM5A (0.39) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL4669071 0.77 KDM5A (0.44) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL11594646 0.74 KDM5A (0.41) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL10323213 0.74 KDM5A (0.41) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL10323234 0.72 KDM5A (0.40) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL7471043 0.71 ALOX5 (0.50) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL27865497 0.69 TDP1 (0.42) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL28235473 0.69 TDP1 (0.43) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL5510789 0.68 SIGMAR1 (0.56) KDM5APHF8KDM2AKDM4CKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2195314-A1 DISUBSTITUTED ALKYL-8-AZABICYCLO [3.2.1.]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2010-06-16 EP disclosed
WO-2009029257-A1 DISUBSTITUTED ALKYL-8-AZABICYCLO [3.2.1.] OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2009-03-05 WO disclosed